New Drug Approval Process in India: A Practical Guide
A lot of pharmaceutical companies spend millions of dollars trying to get their drug approved in India. And still, many of them fail. The thing is, the Indian drug approval process is strict, and small mistakes are made at the wrong stage.
The delays and rejections usually come from basic gaps, unclear documentation, weak CTD structure, or missed compliance steps. These are not big errors, but they cost months or even years.
In this guide, we’ll break down the complete new drug approval process in India, the common mistakes that delay approvals, and finally the important steps after approval to avoid license suspension.












